Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades
Cancer Medicine2020Vol. 9(11), pp. 3765–3774
Citations Over TimeTop 10% of 2020 papers
Weiping Liu, Xinqiang Ji, Yuqin Song, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Meng Wu, Feier Feng, Xin Leng, Yingli Sun, Tingting Du, Jun Zhu
Abstract
The survival of most types of lymphoma such as cHL and mature BCL, rather than PTCL, was improved significantly during the past two decades.
Related Papers
- → Coexisting Follicular and Mantle Cell Lymphoma With Each Having an In Situ Component(2010)53 cited
- → Frequent epigenetic inactivation of Rb1 in addition to p15 and p16 in mantle cell and follicular lymphoma(2007)35 cited
- → Minimale Resterkrankung bei follikulären Lymphomen und Mantellzell-Lymphomen(2005)
- → Bridging Chemotherapy: Follicular Lymphoma, Mantle Cell Lymphoma, and CLL(2022)
- → Follicular Lymphoma and Mantle Cell Lymphoma(2009)